The mistake I see constantly: people pick a GLP-1 telehealth provider based on the flashiest ad or the biggest brand name, then realize months later they’re paying three or four times what a comparable service charges. Name recognition is not the same as value. Here’s how I’d actually work through this category right now, with a shortlist that holds up.
1. HealthRX
Compounded semaglutide at $99 a month is where HealthRX opens the conversation, with tirzepatide at $149. Those are genuinely low numbers compared to most cash-pay telehealth options in this space. But price alone wouldn’t land them at the top of my list.
What keeps them here is the pharmacy specifics. Medication is dispensed through Manifest Pharmacy in Greer, South Carolina, a 503A compounding pharmacy operating under USP-797 standards with lot-to-door tracking. That’s a named facility you can look up, not a vague “partner lab.” They’re LegitScript certified (cert 50087439) and HIPAA compliant. Free overnight shipping goes to all 50 states, which almost no competitor matches without a fee or a geographic asterisk. Your intake form goes to a board-certified physician who typically completes the review within about a day.
One thing to be clear about: these are compounded medications, not FDA-approved branded drugs. The trial data they reference, around 15% body weight reduction for semaglutide and about 21% for tirzepatide over 68-72 weeks, comes from the STEP 1 and SURMOUNT-1 clinical trials on the branded molecules, not HealthRX’s own outcomes. Still, for someone paying cash and wanting a traceable pharmacy chain at the lowest monthly price I’ve found, this is where I’d start.
2. FormBlends
FormBlends is worth a serious look if you want published purity documentation before anything enters your body. They post HPLC purity percentages, mass spec identity results, and endotoxin and sterility data per product. Most GLP-1 telehealth brands say the word “quality” and move on. FormBlends shows the numbers.
Per-vial pricing lands near $299 for compounded semaglutide and $349 for tirzepatide. Notably higher than HealthRX’s entry pricing, which is why FormBlends ranks here rather than first. Physician oversight is part of the model, dispensing goes through an FDA-registered 503A pharmacy, and they ship to 47 states. The wider catalog is a real differentiator too. They carry peptides in the recovery, longevity, and cognitive categories under the same clinician-supervised model, something almost no GLP-1-only telehealth brand offers. If you’re already curious about that category, consolidating providers has real practical value.
3. Mochi Health
Mochi uses board-certified obesity-medicine clinicians, not just general practitioners, which matters if you want someone who treats metabolic issues specifically. Monthly pricing runs roughly $99 for compounded semaglutide and $199 for tirzepatide. Monitoring is more involved than some bare-bones platforms, which I see as a feature for people who want a structured clinical experience rather than a quick prescription.
4. Hims & Hers
After Novo Nordisk’s March 2026 settlement, Hims & Hers moved away from compounded GLP-1s and now focuses on branded medications. Injectable Wegovy runs about $299 a month through their platform, oral options around $249, and Zepbound at approximately $399. With insurance and a savings card, some people get to $0-25. If you have good insurance or qualify for manufacturer savings, this can undercut the cash-pay compounders significantly. Just understand you’re in a different product category now.
5. Ro Body
Ro’s membership starts around $39 for the first month, then settles into the $74-149 range, with medications billed separately. Their prior authorization team actively works with insurance, which is a practical benefit most people underestimate when starting a branded GLP-1. If getting insurance to cover Wegovy or Zepbound is your goal, Ro has more infrastructure for that fight than most.
6. PlushCare
At roughly $19.99 a month for membership, PlushCare is the lightest-touch option here. Same-day visits are available, branded meds are accessible, and insurance is accepted. It’s more of a general telehealth platform that happens to prescribe GLP-1s than a weight-loss-focused program. If you already know what you want and just need a prescription path, that’s fine. If you want coaching or close monitoring, look elsewhere.
A note on timing: the FDA sent warning letters to more than 30 telehealth and compounding firms in early 2026, and the regulatory picture around compounded GLP-1s keeps shifting. Prices and availability here reflect early 2026 public information and can change.
Common Questions
Does it matter which pharmacy a semaglutide telehealth service uses?
Yes, significantly. A named 503A pharmacy operating under USP-797 standards gives you a traceable supply chain and a facility you can look up independently. Services that list only a vague “partner lab” offer no way to verify quality. HealthRX names Manifest Pharmacy specifically; FormBlends publishes HPLC and sterility data. That transparency gap between providers is real.
Is compounded semaglutide from services like HealthRX or Mochi the same as branded Wegovy?
Not exactly. Compounded semaglutide uses the same active molecule, but it is not FDA-approved and has not gone through the same approval process as Wegovy. The weight-loss percentages cited by compounding telehealth services come from clinical trials on the branded drug, not their own patient outcomes. That distinction matters when evaluating any efficacy claims.
Why did Hims & Hers stop offering compounded GLP-1s while HealthRX and FormBlends still do?
Hims & Hers exited compounded GLP-1s following Novo Nordisk’s March 2026 settlement, which affected how certain platforms could operate in that space. HealthRX and FormBlends continue offering compounded versions through 503A pharmacies, which operate under a separate regulatory framework. The legal and regulatory picture here keeps shifting, so what’s available from any given provider can change with little notice.
If I want insurance to cover my GLP-1, which of these services actually helps with that?
Ro Body has the most developed prior authorization infrastructure among the services listed here. Their team actively works the insurance process on your behalf, which can make a real difference since insurer denials on GLP-1s are common on the first attempt. Hims & Hers and PlushCare also accept insurance, but neither is specifically built around fighting that approval process the way Ro is.
What separates Mochi Health from a low-cost prescription-only platform like PlushCare?
The clinical depth. Mochi uses obesity-medicine specialists rather than general practitioners, and the monitoring is more structured throughout treatment. PlushCare at $19.99 a month is essentially a prescription pathway with minimal ongoing support. If you want a clinician who tracks metabolic markers and adjusts your protocol over time, Mochi is closer to that model. If you just need the script, PlushCare is cheaper.
Sources
- FDA rules governing compounding pharmacies and 503A facilities, FDA.gov
- Wilding et al., semaglutide weight-loss outcomes, NEJM 2021 (STEP 1)
- Jastreboff et al., tirzepatide weight-loss outcomes, NEJM 2022 (SURMOUNT-1)
- LegitScript pharmacy certification database
- Novo Nordisk compounding settlement, public announcements March 2026
- Publicly listed pricing pages for Hims & Hers, Ro, Mochi Health, PlushCare (accessed 2026)
